Form Type: 4

SEC EDGAR Link
Accession Number:0001209191-19-059883
Date:2019-12-09
Issuer: VERTEX PHARMACEUTICALS INC / MA (VRTX)
Original Submission Date:

Reporting Person:

SACHDEV AMIT
C/O VERTEX PHARMACEUTICALS INCORPORATED
50 NORTHERN AVENUE BOSTON, MA 02210

Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
Title of SecurityTransaction Date2a. Deemed Execution Date Transaction CodeSharesAcquired or DisposedPrice per share 5. Amount of Securities Beneficially Owned Following Reported Transaction 6. Ownership Form Direct or IndirectNature of Indirect Ownership
COMMON STOCK 2019-12-09 M 5,000 a $109.14 38,416 direct
COMMON STOCK 2019-12-09 S 5,000 d $225.00 33,416 direct
COMMON STOCK 2019-12-09 0 $0.00 882 indirect
COMMON STOCK 2019-12-09 0 $0.00 18,964 indirect
Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, convertible securities
Title of Derivative Security Conversion or Exercise Price of Derivative Security Transaction Date Deemed Execution Date Transaction Code Number of Derivative Securities Acquired (A) or Disposed of (D) Date ExercisableExpiration Date Title and Amount of Securities Underlying Derivative Security Price of Derivative Security Number of derivative Securities Beneficially Owned Following Reported Transaction(s) Ownership Form: Direct (D) or Indirect (I) Nature of Indirect Beneficial Ownership
STOCK OPTION (RIGHT TO BUY) 109.14 2019-12-09 deemed execution date M 5,000 (d) 2025-02-02 common stock 5,000 $109.14 42,500 direct
Footnotes
IDfootnote
f1 transaction made pursuant to mr. sachdev's company approved trading plan under rule 10b5-1.
f2 fully vested.
WhaleWisdom Logo

Elevate your investments